The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Ab
Aconitum Napellus, Bryonia Cretica · ACONITUM NAPELLUS 3 [hp_X]/100mL; BRYONIA CRETICA SUBSP. DIOICA ROOT 3 [hp_X]/100mL · Liquid · Oral · Marco Pharma International Llc
NDC 60986-2040-03 · 50 mL in 1 BOTTLE · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Aconitum Napellus, Bryonia Cretica (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Marco Pharma International Llc | ACONITUM NAPELLUS 3 [hp_X]/100mL; BRYONIA CRETICA SUBSP. DIOICA ROOT 3 [hp_X]/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Nestmann Pharma GmbH | BRYONIA CRETICA SUBSP. DIOICA ROOT 3 [hp_X]/100mL; ACONITUM NAPELLUS 3 [hp_X]/100mL | Jul 22, 2026 | Sep 2, 2026 |
| Nestmann Pharma GmbH | ACONITUM NAPELLUS 3 [hp_X]/100mL; BRYONIA CRETICA SUBSP. DIOICA ROOT 3 [hp_X]/100mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Ab — NDC 60986-2040-03," retrieved September 3, 2026, https://drugdashboards.com/drug/60986204003.
Free to cite with attribution — see how the data is put together.